Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Breast Cancer

  Free Subscription


Articles published in Carcinogenesis

Retrieve available abstracts of 31 articles:
HTML format



Single Articles


    March 2024
  1. KIM H, Son S, Ko Y, Lim H, et al
    CYR61 confers chemoresistance by upregulating survivin expression in triple-negative breast cancer.
    Carcinogenesis. 2024 Mar 6:bgae013. doi: 10.1093.
    PubMed     Abstract available


    December 2023

  2. Retraction of: Genetic and clinical characteristics of BRCA-associated hereditary breast cancer in the West region of Kazakhstan.
    Carcinogenesis. 2023 Dec 14:bgad083. doi: 10.1093.
    PubMed    


    November 2023
  3. YANG H, Li S, Li W, Yang Y, et al
    Actinomycin D Synergizes with Doxorubicin in Triple-Negative Breast Cancer by Inducing P53-Dependent Cell Apoptosis.
    Carcinogenesis. 2023 Nov 24:bgad086. doi: 10.1093.
    PubMed     Abstract available


    October 2023
  4. XIAO B, Xiang Q, Deng Z, Chen D, et al
    KCNN1 promotes proliferation and metastasis of breast cancer via ERLIN2-mediated stabilization and K63-dependent ubiquitination of Cyclin B1.
    Carcinogenesis. 2023 Oct 13:bgad070. doi: 10.1093.
    PubMed     Abstract available


  5. ACTIS S, Cazzaniga M, Bounous VE, D'Alonzo M, et al
    Emerging evidence on the role of breast microbiota on the development of breast cancer in high-risk patients.
    Carcinogenesis. 2023 Oct 4:bgad071. doi: 10.1093.
    PubMed     Abstract available


    September 2023
  6. WANG Y, Pang X, Liu Y, Mu G, et al
    SOCS1 acts as a ferroptosis driver to inhibit the progression and chemotherapy resistance of triple-negative breast cancer.
    Carcinogenesis. 2023 Sep 4:bgad060. doi: 10.1093.
    PubMed     Abstract available


    August 2023
  7. LIU B, Fu X, Du Y, Feng Z, et al
    Pan-cancer analysis of G6PD carcinogenesis in human tumors.
    Carcinogenesis. 2023;44:525-534.
    PubMed     Abstract available


    June 2023
  8. HAN S, Jin X, Hu T, Chi F, et al
    ARHGAP25 suppresses the development of breast cancer by an ARHGAP25/Wnt/ASCL2 feedback loop.
    Carcinogenesis. 2023 Jun 16:bgad042. doi: 10.1093.
    PubMed     Abstract available


    April 2023
  9. ZHU M, Wu C, Wu X, Song G, et al
    POP1 promotes the progression of breast cancer through maintaining telomere integrity.
    Carcinogenesis. 2023 Apr 3:bgad017. doi: 10.1093.
    PubMed     Abstract available


    January 2023

  10. Correction to: SOX8 acts as a prognostic factor and mediator to regulate the progression of triple-negative breast cancer.
    Carcinogenesis. 2023 Jan 30:bgad002. doi: 10.1093.
    PubMed    


    November 2022
  11. YIN X, Li G, Fan D, Ge Z, et al
    Ehm2 transcript variant 1 inhibits breast cancer progression and increases E-cadherin stability.
    Carcinogenesis. 2022 Nov 24:bgac076. doi: 10.1093.
    PubMed     Abstract available


    October 2022
  12. ZHAO L, Lei J, Gu S, Zhang Y, et al
    A yes-associated protein 1-Notch1 positive feedback loop promotes breast cancer lung metastasis by attenuating the Bone morphogenetic protein 4-SMAD family member 1/5 signaling.
    Carcinogenesis. 2022 Oct 4. pii: 6748174. doi: 10.1093.
    PubMed     Abstract available


    September 2022
  13. ZHOU LX, Zheng H, Tian Y, Luo KF, et al
    SNCA inhibits epithelial-mesenchymal transition and correlates to favorable prognosis of breast cancer.
    Carcinogenesis. 2022 Sep 30. pii: 6732370. doi: 10.1093.
    PubMed     Abstract available


    August 2022
  14. AITMAGAMBETOVA MA, Smagulova GA, Tuhvatshin RR, Zheksenova AN, et al
    Genetic and clinical characteristics of BRCA-associated hereditary breast cancer in the West region of Kazakhstan.
    Carcinogenesis. 2022 Aug 2. pii: 6653490. doi: 10.1093.
    PubMed     Abstract available


    July 2022
  15. MOU J, Xu X, Wang F, Kong W, et al
    HMGN4 plays a key role in STAT3-mediate oncogenesis of triple-negative breast cancer.
    Carcinogenesis. 2022 Jul 6. pii: 6632630. doi: 10.1093.
    PubMed     Abstract available


    June 2022

  16. Retraction to: 2-Tellurium-bridged beta-cyclodextrin, a thioredoxin reductase inhibitor, sensitizes human breast cancer cells to TRAIL-induced apoptosis through DR5 induction and NF-kappaB suppression.
    Carcinogenesis. 2022 Jun 22. pii: 6610927. doi: 10.1093.
    PubMed    


  17. SUMAN P, Mehta V, Craig AWB, Chander H, et al
    Wild-type p53 suppresses formin-binding protein-17 (FBP17) to reduce invasion.
    Carcinogenesis. 2022;43:494-503.
    PubMed     Abstract available


    May 2022

  18. Correction to: tRNA-derived fragment tRFLys-CTT-010 promotes triple-negative breast cancer progression by regulating glucose metabolism via G6PC.
    Carcinogenesis. 2022 May 31. pii: 6596197. doi: 10.1093.
    PubMed    


  19. BICER A, Lopez-Henares P, Feu-Llaurado A, Sabariego M, et al
    The PxIxIT motif of the RCAN3 Inhibits angiogenesis and tumor progression in Triple Negative Breast Cancer in Immunocompetent Mice.
    Carcinogenesis. 2022 May 30. pii: 6594970. doi: 10.1093.
    PubMed     Abstract available


  20. LI N, Wang X, Sun J, Liu Y, et al
    miR-21-5p/Tiam1-mediated glycolysis reprogramming drives breast cancer progression via enhancing PFKL stabilization.
    Carcinogenesis. 2022 May 2. pii: 6577054. doi: 10.1093.
    PubMed     Abstract available


    March 2022
  21. ELISIA I, Yeung M, Wong J, Kowalski S, et al
    A low-carbohydrate diet containing soy protein and fish oil reduces breast but not prostate cancer in C3(1)/Tag mice.
    Carcinogenesis. 2022;43:115-125.
    PubMed     Abstract available


    January 2022
  22. CHEN M, Li S, Srinivasasainagendra V, Sharma M, et al
    Maternal soybean genistein on prevention of later-life breast cancer through inherited epigenetic regulations.
    Carcinogenesis. 2022 Jan 27. pii: 6515999. doi: 10.1093.
    PubMed     Abstract available


    December 2021
  23. XU R, Yan Y, Zheng X, Zhang H, et al
    Aspirin Suppresses Breast Cancer Metastasis to Lung by Targeting Anoikis Resistance.
    Carcinogenesis. 2021 Dec 27. pii: 6484923. doi: 10.1093.
    PubMed     Abstract available


  24. PARK J, Huang D, Chang YJ, Lim MC, et al
    Oral contraceptives and risk of breast cancer and ovarian cancer in women with a BRCA1 or BRCA2 mutation: A meta-analysis of observational studies.
    Carcinogenesis. 2021 Dec 27. pii: 6484912. doi: 10.1093.
    PubMed     Abstract available


  25. ZENG Q, Jin F, Qian H, Chen H, et al
    The miR-345-3p/PPP2CA signaling axis promotes proliferation and invasion of breast cancer cells.
    Carcinogenesis. 2021 Dec 18. pii: 6469523. doi: 10.1093.
    PubMed     Abstract available


  26. HUANG S, Shu X, Ping J, Wu J, et al
    TBX1 functions as a putative oncogene of breast cancer through promoting cell cycle progression.
    Carcinogenesis. 2021 Dec 17. pii: 6469002. doi: 10.1093.
    PubMed     Abstract available


  27. SHLIAKHTUNOU YA, Siamionau VM, Pobyarzhin VV
    Transcription phenotype of circulating tumor cells in non-metastatic breast cancer.
    Carcinogenesis. 2021 Dec 17. pii: 6469006. doi: 10.1093.
    PubMed     Abstract available


    October 2021
  28. AL-JOMAH N, Al-Mohanna FH, Aboussekhra A
    Tocilizumab suppresses the pro-carcinogenic effects of breast cancer- associated fibroblasts through inhibition of the STAT3/AUF1 pathway.
    Carcinogenesis. 2021 Oct 30. pii: 6414472. doi: 10.1093.
    PubMed     Abstract available


  29. CHO BA, Iyengar NM, Zhou XK, Morrow M, et al
    Blood biomarkers reflect the effects of obesity and inflammation on the human breast transcriptome.
    Carcinogenesis. 2021;42:1281-1292.
    PubMed     Abstract available


  30. GODINA C, Khazaei S, Tryggvadottir H, Visse E, et al
    Prognostic impact of tumor-specific insulin-like growth factor binding protein 7 (IGFBP7) levels in breast cancer: A prospective cohort study.
    Carcinogenesis. 2021 Oct 4. pii: 6380882. doi: 10.1093.
    PubMed     Abstract available


    July 2021
  31. RAHMAN MM, Herath D, Bladen JC, Atkar R, et al
    Differential expression of phosphorylated MEK and ERK correlates with aggressive BCC subtypes.
    Carcinogenesis. 2021;42:975-983.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.